Back to Search
DON DIZON, MD
Medical Oncology Physician
NPI: 1376573394IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
222651(MA)
Education
UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Class of 1995
Research & Publications (20)
Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-P.
PMID 19451430·J Clin Oncol·2009
3-trial
Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases.
PMID 18722916·Surg Oncol Clin N Am·2008
6-review
For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
PMID 18376226·Am J Clin Oncol·2008
8-other
Does one person provide it all? Primary support and advanced care planning for women with cancer.
PMID 17416861·J Clin Oncol·2007
8-other
Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient.
PMID 16804313·Gynecol Obstet Invest·2006
5-case
Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program.
PMID 16197986·Gynecol Oncol·2006
8-other
Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer.
PMID 16336992·Gynecol Oncol·2006
8-other
Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience.
PMID 14675681·Gynecol Oncol·2003
4-observational
Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy.
PMID 11855873·Gynecol Oncol·2002
5-case
Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer.
PMID 11870166·J Clin Oncol·2002
8-other
Intrahepatic arterial infusion of chemotherapy: clinical results.
PMID 11951210·Semin Oncol·2002
6-review
Is there a taxane-free interval that predicts response to taxanes as a later-line treatment of recurrent ovarian or primary peritoneal cancer?
PMID 19407557·Int J Gynecol Cancer·2009
8-other
Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
PMID 19359030·Gynecol Oncol·2009
8-other
Society of gynecologic oncologists position paper: breast cancer care.
PMID 18589209·Gynecol Oncol·2008
8-other
Impaired placental trophoblast lineage differentiation in Alkbh1(-/-) mice.
PMID 18163532·Dev Dyn·2008
4-observational
Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital.
PMID 17157366·Gynecol Oncol·2007
8-other
Sex, intimacy, and the gynecologic oncologists: survey results of the New England Association of Gynecologic Oncologists (NEAGO).
PMID 18032265·J Psychosoc Oncol·2007
8-other
Clinical characteristics of women presenting with skin-only recurrence of breast cancer.
PMID 17826063·Am J Surg·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 DUDLEY ST
PROVIDENCE, RI 02905 - Phone
- (401) 274-1100
Quick Facts
- NPI
- 1376573394
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile